Synlogic Inc (SYBX)
1.75
-0.03
(-1.69%)
USD |
NASDAQ |
Mar 28, 12:32
Synlogic Cash from Investing (TTM): 38.77M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 38.77M |
September 30, 2023 | 68.26M |
June 30, 2023 | 77.21M |
March 31, 2023 | 68.86M |
December 31, 2022 | 58.35M |
September 30, 2022 | 10.18M |
June 30, 2022 | 8.709M |
March 31, 2022 | -33.65M |
December 31, 2021 | -53.25M |
September 30, 2021 | -12.84M |
June 30, 2021 | -9.024M |
March 31, 2021 | 26.82M |
December 31, 2020 | 32.48M |
September 30, 2020 | 35.38M |
June 30, 2020 | 53.54M |
March 31, 2020 | -1.062M |
December 31, 2019 | 10.80M |
Date | Value |
---|---|
September 30, 2019 | 3.704M |
June 30, 2019 | -16.61M |
March 31, 2019 | 2.342M |
December 31, 2018 | -87.20M |
September 30, 2018 | -101.60M |
June 30, 2018 | -95.33M |
March 31, 2018 | -66.47M |
December 31, 2017 | 9.278M |
September 30, 2017 | 15.81M |
June 30, 2017 | 10.51M |
March 31, 2017 | -16.75M |
December 31, 2016 | -48.49M |
September 30, 2016 | -43.60M |
June 30, 2016 | -45.02M |
March 31, 2016 | -28.11M |
December 31, 2015 | -0.251M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-53.25M
Minimum
Dec 2021
77.21M
Maximum
Jun 2023
18.45M
Average
10.49M
Median
Cash from Investing (TTM) Benchmarks
BioXcel Therapeutics Inc | -0.02M |
Inotiv Inc | -24.64M |
IGM Biosciences Inc | 68.36M |
Humacyte Inc | 5.189M |
Moderna Inc | 4.206B |